Latest News

Biomarkers Enhance Astra Zeneca's Clinical Trial Successes // ImmunoSite Technologies

Biomarker data from Astra Zeneca demonstrates that biomarkers enhance success in every aspect (safety, dosing, efficacy, patient selection) of every state of the drug Therapeutic Vaccinedevelopment process.  The huge investment in a new testing paradigm to address the new types of therapeutics was worth it for AZ, and will benefit not only all companies in the pharmaceutical industry, but mankind since we can expect to see an increase in the number of efficacious therapies sooner rather than later!

Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework.  David Cook,Dearg Brown, Robert Alexander, Ruth March, Paul Morgan, Gemma Satterthwaite & Menelas N. Pangalos.  Nature Reviews Drug Discovery (2014).  DOI: doi:10.1038/nrd4309. Published online 16 May 2014

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter

ImmunoSite Receives 2013 Innovative Business Award // ImmunoSite Technologies

ImmunoSite Technologies, LLC was receives ImmunoSite_2013_Business_Innovation_Awardthe 2013 Innovative Business award from BB&T in December, for their innovative services and custom products provided to Pharmaceutical and other Life Science industries globally.  Congratulations to all of the winners: WorkForce One, Downtown Development Authority, Hilton Fort Lauderdale Beach Resort, ProdecoTech, United Way of Broward County, Broward Health Medical Center, Community Foundation of Broward County, Broward College, FP&L, Resolve Marine Group, ImmunoSite Technologies and SmartWater CSI.

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter

ImmunoSite Receives National MBE Certification // ImmunoSite Technologies

SFMSDC02/01/2014. ImmunoSite Technologies was certified as a National MBE, Minority Business Enterprise, by the Southern Florida Minority Supplier Development Council as defined by the U.S. National Minority Supplier Development Council.  The NMSDC was chartered in 1972 and is one of the country’s leading corporate membership organizations to advance business opportunities for certified business enterprises of all sizes, by connecting MBEs with corporate members interested in maintaining supplier diversity in their businesses. There are over 3,500 corporate members, including most of America’s largest public, private and foreign-owned companies, as well as universities, hospitals and other buying institutions.

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter

ImmunoSite Technologies Expands into New Spacious Facility in Miramar // ImmunoSite Technologies

Press Release, February 28, 2013

ImmunoSite Technologies, LLC (IST), a provider of automation, design and customization of complex biological assays to biotechnology and pharmaceutical industries worldwide, announced its relocation to a newly expanded facility at 2831 Corporate Way in Miramar.  With the expansion, the company will be retaining its current employees, making a capital investment of $150,000 and adding 5 new jobs that will focus on product development.

READ MORE

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter

2013 SLAS 2nd Annual Conference & Exhibition // ImmunoSite Technologies

Executives, Engineers, and Scientists from ImmunoSite Technologies attended the Annual 2013 SLAS meeting in Orlando, Florida and brought back some of the latest technologies to integrate into new automated solutions for biological assay automation that will enhance their client’s productivity even more!

Call IST to discuss your automation needs at (888) 770-4478

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter

ImmunoSite Technologies Aides in Curriculum Development for Employ Florida Banner Center // ImmunoSite Technologies

Cell Culture Course helps Floridians enter, remain and advance in the workforce


Fort Lauderdale, Fla. – October 18, 2011 –
ImmunoSite Technologies (IST), LLC, a leading provider of immune monitoring services, has helped to develop a Cell Culture Workshop that is offered  at the Employ Florida Banner Center for Life Sciences, based at Palm Beach State College’s Eissey Campus in Palm Beach Gardens.

READ MORE

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter

ImmunoSite Technologies Provides Particle Testing Services to Beckman Coulter Customers // Admin

Leading provider of particle testing services now receives referrals of customers seeking particle characterization services from Beckman Coulter, Inc.

Fort Lauderdale, Fla. April 3, 2011 ImmunoSite Technologies, LLC, a leading provider of immune monitoring services, is now receiving direct customer referrals for particle testing services from Beckman Coulter, Inc. as part of a recent collaboration agreement.

READ MORE

Share this:
  • Print
  • Digg
  • Facebook
  • email
  • LinkedIn
  • Twitter